World Congress on Biosensors 2014

World Congress on Biosensors 2014
Biosensors 2014

Thursday, 1 March 2012

New 2012 Primary Cell Isolation & Tissue Dissociation Guide Available!

Worthington Biochemical's updated 2012 Tissue Dissociation Guide is now available to assist researchers with selecting enzymes, developing and optimizing protocols and better understanding the process of enzymatic primary cell isolation and tissue dissociation.
The guide also discusses the enzymes most commonly used, their handling and specificity, and includes hundreds of new detailed cell and species-specific primary cell isolation references.
To obtain a copy of the NEW Tissue Dissociation Guide, call: 800.445.9603 • 732.942.1660 or Fax: 800-368-3108 • 732-942-9270. The catalog may also be obtained at www.worthington-biochem.com or E-mail CustService@worthington-biochem.com
Worthington Biochemical Corp. was founded in 1947 by Charles C. Worthington in Freehold, New Jersey. Over the years, its purpose has been the production of the highest quality enzymes and biochemicals for life science research and bioprocessing applications.

White Paper Examines Factors Affecting CHN Elemental Analysis

Exeter Analytical Inc. has written a white paper that discusses how CHN elemental analyzer design affects operational accuracy and precision, ease of use and handling of demanding sample types.  The report examines the consequences of different commercial CHN elemental analyzer designs when the systems are run in real lab environments. 

Data is provided showing the impact of horizontal versus vertical combustion systems. In a horizontal furnace arrangement the sample is introduced into the combustion tube on a quartz ladle, which critically enables the removal of all sample residues after combustion.  In a vertical furnace arrangement the samples are combusted on top of previously combusted samples.  This difference is a major factor contributing to the advantages of a static system with a horizontal furnace over both the dynamic and hybrid designs.  The build up of sample residue in the combustion zone of vertical furnace systems is shown to considerably increase the potential for poor analytical data.

The most important criteria for CHN analysis in the majority of analytical laboratories is for optimal accuracy and precision across a wide range of sample types. With constant pressure to increase laboratory productivity an analyst does not want to set up their analyzer with different operational parameters for every different sample type they come across.  Test data from an independent multi-laboratory study is included in the white paper demonstrating not only the superior accuracy and precision routinely achievable, but also how the inherently longer term stability with a horizontal furnace design markedly decreases time lost due to the need for recalibrations and sample re-runs.

Considerable variance in instrument performance can also be seen with more demanding samples.  The advantages of a horizontal furnace design CHN elemental analyzer is illustrated with applications including time-dependent combustible samples and volatile liquids.

The report concludes that using a horizontal furnace design CHN elemental analyzer, such as the Exeter Analytical Model 440, allows analysts to routinely and simply produce accurate and precise data on wide ranging sample types without system re-optimization, saving precious time and reducing running costs.

For a copy of the white paper 'How instrument design affects CHN micro-analytical performance' please contact Exeter Analytical Inc. on tel. +1-978-251-1411 (+44-2476-323223 in Europe) or email sales@eai1.com (info@exeteranalytical.co.uk in Europe).

Wednesday, 29 February 2012

Just Published: Sensors & Actuators B: Chemical

A new issue of this journal has just been published. To see abstracts of the papers it contains (with links through to the full papers) click here:
Selected papers from the latest issue:

Enhanced response characteristics of SnO2thin film based sensors loaded with Pd clusters for methane detection

29 February 2012, 02:16:20Go to full article
Publication year: 2012
Source: Sensors and Actuators B: Chemical, Available online 28 February 2012
Divya Haridas, Vinay Gupta
This paper reports the response characteristics of rf-sputtered SnO2thin films (90 nm thin) loaded with nanoscale catalytic clusters for detection of methane. Ultrathin (8 nm) metal and metal-oxide catalysts (Pt, Ag, Ni, Pd, Au, NiO, Au2O3) clusters are loaded over the surface of SnO2thin film. The SnO2-Pd cluster structure is found to exhibit an enhanced response (97.2%) for 200 ppm of methane at a relatively low operating temperature (220 °C). The enhanced response is shown to be primarily due to the dominant roles played by both Fermi level energy control mechanism and spillover mechanism. Thickness of the Pd catalyst clusters in the nano-scale range (2 to 20 nm), influences significantly the sensor characteristics. Optimized performance is observed with 10 nm thick Pd catalyst clusters showing a high response (∼99.2%) at a relatively low operating temperature of 160 °C. Thickness of the Pd clusters is shown to influence the amount of adsorbed oxygen present on the uncovered SnO2film surface and also activates the spillover mechanism. The results suggest the possibility of utilizing the sensor structure having novel dispersal of Pd catalyst clusters (10 nm thickness) on the surface of SnO2thin film for efficient detection of methane gas.

Polymer-assisted synthesis of metallopolymer nanocomposites and their applications in liquefied petroleum gas sensing at room temperature

29 February 2012, 02:16:20Go to full article
Publication year: 2012
Source: Sensors and Actuators B: Chemical, Available online 28 February 2012
Satyendra Singh, B.C. Yadav, Poonam Tandon, Mridula Singh, Anuj Shukla, ...
In this paper, the synthesis of the acrylamide complex of Co (II) nitrate followed by polymerization and formation of a polymer composite with inclusions of Co nanoparticles stabilized by the polymer matrix has been reported. Cobalt polyacrylamide (Co/PAAM) was prepared by the procedure including formation of cobalt acrylamide complex, followed by frontal polymerization and pyrolysis of the polymer. Structural investigations of the materials were carried out by X-ray diffractometer. Surface morphologies were analysed using scanning electron microscope and nano-structural properties were studied by using high resolution transmission electron microscope and atomic force microscope. Phase transformation temperature was evaluated using a differential scanning calorimeter. The crystallite size of the Co/PAAM was found ∼ 6 nm and confirmed by TEM analysis. Thick films of the metallopolymers were made by screen printing technique and these were investigated with exposition of LPG for measurements of LPG sensing characteristics. Larger variations in resistance were found for Co/PAAM in comparison to Co(NO3)2.(AAM)4.2H2O. The maximum values of the sensitivities were 2.9 and 23.6 MΩ/sec for Co(NO3)2.(AAM)4.2H2O and Co/polyacrylamide respectively. The reproducibility of the sensor made of Co/PAAM film was found to be 96% after one month of observations, which shows the stability and reliability of the fabricated sensor

Scaling laws and performance improvements of integrated biosensor microarrays with multi-pixel per spot

29 February 2012, 02:16:20Go to full article
Publication year: 2012
Source: Sensors and Actuators B: Chemical, Available online 28 February 2012
N. Couniot, A. Afzalian, D. Flandre
Multiplexed, real-time and low cost detection of bioanalytes can be achieved by building integrated biosensor microarrays. The lack of design guidelines for this kind of biochip leads to inferior results compared to individual biosensors. In this paper, we thoroughly study the impact of considering several pixels per spot on the performances of integrated biosensor microarrays. By taking into account the biological shot noise and electrical characteristics of the transducer, we theoretically calculate how dividing each spot into several pixels improves the limit of detection and the resolution of the overall biosensor microarray without degrading the signal-to-noise ratio. More particularly, we show that the improvement of the limit of detection depends on the individual biosensor performance while the resolution is enhanced proportionally to the square root of number of pixels per spot. Performance trade-offs, CMOS compatibility and numerical results for optical, field-effect and capacitive biosensor microarrays having multiple pixels per spot are finally established.

Leading Genomic Service Provider Selects Fluidigm Access Array Sample Prep Technology

MOgene, LC, a leading genomics service provider located in St. Louis, is implementing Fluidigm Access Array™ sample preparation technology for its targeted resequencing customers. The Access Array System is the only system that prepares amplicons for resequencing without the need for any additional library preparation while providing the lowest running costs in the industry and the flexibility to operate with any next-generation sequencer on the market.

"We purchased a Fluidigm Access Array System to provide high-throughput target enrichment for all major sequencing equipment," said Shaukat Rangwala, vice president, MOgene, LC. "Since 2004, MOgene has been involved with numerous sequencing projects such as transcriptomes, metagenomics and notably sequencing the oil palm genome as a member of the consortium working with Washington University and Orion Genomics. We believe adding the Access Array's capabilities will be a great addition to our sequencing offerings," Rangwala concluded.

"For almost a decade, MOgene has been providing genomics services to the pharmaceutical, biotech, academic, and government markets. We are extremely excited to have them incorporate the Fluidigm Access Array technology into their service portfolio. MOgene's focus on providing their customers with high quality genomics solutions based on industry leading technology has been a hallmark of their success in the market," said Gajus Worthington, Fluidigm president and chief executive officer.

MOgene is a leading global genomics service provider located in St. Louis, Missouri. MOgene offers a full range of genomic services from RNA/DNA isolation, microarrays, real-time PCR, NGS to complete analysis. Since 2004, the company has been involved with numerous sequencing projects such as transcriptomes, metagenomics and notably sequencing the oil palm genome as a member of the consortium with Washington University and Orion Genomics. MOgene recently purchased Fluidigm Access Array System to provide high-throughput target enrichment for all major sequencing instruments. MOgene also upgraded its 454 to FLX plus generating even longer reads. MOgene has demonstrated achieving a billion bases in a shotgun run. The company is a long time Agilent-certified service provider for gene expression, CGH, ChIP, miRNA and methylation microarrays. In the area of bioinformatics, the company works with its customers to provide customized solutions and publication-ready analysis. For more information, visit http://mogene.com/

Lloyd Instruments UK And Ireland Service And Support Further Strengthened

Lloyd Instruments, a world-renowned manufacturer of materials testing machines and part of AMETEK Inc., has further strengthened its service and support team in the UK and Ireland with the addition of two further regional Service Engineers. As part of a financially sound, leading global manufacturer of electronic instruments and electromechanical devices that enjoys annual sales of $3 billion and a 1200-strong workforce in the UK, Lloyd Instruments UK customer support structure has never been stronger.

The new Service Engineers bring over 20 years combined experience in electronics engineering support to the Lloyd Instruments regional Service team. Fast service response across the UK and Ireland is backed by an in-house technical support team which includes Jason Pearce, an engineer with more than 25 years service at Lloyd Instruments. All UK service engineers are UKAS (United Kingdom Accreditation Service) accredited. 

Lloyd Instruments in-house calibration laboratory has also been UKAS accredited for more than 20 years, offering UKAS approved verification and calibration of force measuring systems in tension and compression, including verification of machines from other manufacturers. The laboratory has issued more than 25,000 UKAS accredited (or their equivalent) calibration certificates to UK customers alone. The calibration laboratory is also accredited to ISO 17025-2005.

Customers are fully covered with traceable UKAS certificates from installation of the machine through the length of its life. Installation and training is carried out at the customer's premises and a UKAS certificate issued. At the end of the warranty period customers are contacted concerning machine recalibration and the type of service contract required.

Strong service and technical support is not restricted to the UK and Ireland. The service and support team based in France extends to N. Africa, while in Germany, a similar team provides support across 
Germany, Austria and Switzerland. 

The service department in Denmark is also certified to perform traceable calibration according to UKAS, and AMETEK S.A.S., sister company of Lloyd Instruments in France, is COFRAC accredited (Accreditation N1-0884). COFRAC and UKAS are members of EA  (European cooperation for Accreditation) which is recognized by all European countries as well as all over the World. There is a similar story in other regions. With an international network of distributors offering technical and service support, Lloyd Instruments continues to offer accredited facilities at locations throughout the world. 

Tuesday, 28 February 2012

Just Published: Biosensors & Bioelectronics

A new issue of this journal has just been published. To see abstracts of the papers it contains (with links through to the full papers) click here:
Selected papers from the latest issue:

An Enzymatic Immunoassay Microfluidics Integrated with Membrane Valves for Microsphere Retention and Reagent Mixing

25 February 2012, 21:52:54Go to full article
Publication year: 2012
Source: Biosensors and Bioelectronics, Available online 25 February 2012
Li Ren, Jian-Chun Wang, Wenming Liu, Qin Tu, Rui Liu, ...
The present study presents a new microfluidic device integrated with pneumatic microvalves and a membrane mixer for enzyme-based immunoassay of acute myocardial infarction biomarkers, namely, myoglobin, and heart-type fatty acid binding protein (H-FABP). Superparamagnetic microspheres with carboxyl groups on their surfaces were used as antibody solid carriers. A membrane mixer consisting of four ψ-type membrane valves was assembled under the reaction chamber for on-chip performing microsphere trapping and reagent mixing. The entire immunoassay process, including microsphere capture, reagent input, mixing, and subsequent reaction, was accomplished on the device either automatically or manually. The post-reaction substrate resultant was analyzed using a microplate reader. The results show that the average absorbance value is correlated with the concentration of cardiac markers, in agreement with the results obtained using a conventional microsphere-based immunoassay; this indicated that the proposed on-chip immunoassay protocol could be used to detect both myoglobin and H-FABP. The minimum detectable concentration is 5 ng/mL for myoglobin and 1 ng/mL for H-FABP.

Highlights

► A new and integrated microfluidics for microsphere-based enzymatic immunoassay was described. ► Microsphere retention and reagent mixing were realized via membrane microvalves and a mixer. ► The entire immunoassay process could be accomplished either automatically or manually. ► Two acute myocardial infarction-related early biomarkers were analyzed as case studies.

Label-free reflectometric interference microchip biosensor based on nanoporous alumina for detection of circulating tumour cells

25 February 2012, 21:52:54Go to full article
Publication year: 2012
Source: Biosensors and Bioelectronics, Available online 25 February 2012
Tushar Kumeria, Mahaveer D. Kurkuri, Kerrilyn R. Diener, Luke Parkinson, Dusan Losic
In this report, a label-free reflectometric interference spectroscopy (RIfS) based microchip biosensor for the detection of circulating tumour cells (CTCs) is demonstrated. Highly ordered nanoporous anodic aluminium oxide (AAO) fabricated by electrochemical anodization of aluminium foil was used as the RIfS sensing platform. Biotinylated anti-EpCAM antibody that specifically binds to human cancer cells of epithelial origin such as pancreatic cancer cells (PANC-1) was covalently attached to the AAO surface through multiple surface functionalization steps. Whole blood or phosphate buffer saline spiked with low numbers of pancreatic cancer cells were successfully detected by specially designed microfluidic device incorporating an AAO RIfS sensor, without labour intensive fluorescence labelling and/or pre-enhancement process. Our results show that the developed device is capable of selectively detecting of cancer cells, within a concentrations range of 1,000 to 100,000 cells/mL, with a detection limit of < 1000 cells/mL, a response time of <5 minutes and sample volume of 50 μL of. The presented RIfS method shows considerable promise for translation to a rapid and cost-effective point-of-care diagnostic device for the detection of CTCs in patients with metastatic cancer.

Highlights

► We develop a label-free reflectometric interference spectroscopy (RIfS) microchip biosensor for the detection of circulating tumour cells (CTCs) ► A nanoporous alumina functionlized with biotinylated human anti-EpCAM antibodies is used as a sensing platform ► The measurement of CTCs with concentrations of 1,000 to 200,000 cells/mL in buffer and whole blood is demonstrated. ► The device is highly selective to CTCs, has response time of <5 minutes and requires less than 50 μL of sample.

TiO2/MWNTs Nanocomposites-Based Electrochemical Strategy for Label-Free Assay of Casein Kinase II Activity and Inhibition

25 February 2012, 21:52:54Go to full article
Publication year: 2012
Source: Biosensors and Bioelectronics, Available online 25 February 2012
Xiaoxiao He, Zhifeng Chen, Yonghong Wang, Kemin Wang, Jing Su, ...
In this paper, a novel label-free electrochemical strategy has been developed for assay of casein kinase II (CK2) activity and inhibition using TiO2/MWNTs nanocomposites. This detection system takes advantage of specific binding of the phosphate groups with TiO2nanoparticles and fast electron transfer rate of MWNTs. In this strategy, the synthesized TiO2/MWNTs nanocomposite was firstly deposited on the surface of a glassy carbon electrode (GCE). The presence of MWNTs not only increased the surface area of the electrode but also promoted electron-transfer reaction. In the presence of CK2, the kinase reaction resulted in the phosphorylation of peptide substrates. The phosphorylated peptides were subsequently captured to the surface of GCE modified with TiO2/MWNTs nanocomposite through specific binding of the phosphate groups with TiO2nanoparticles. Then the access of redox probe [Fe(CN)6]to electrode surface was blocked. As a result, the decrease peak currents were related to the concentrations of the CK2, providing a sensing mechanism for monitoring peptides phosphorylation. The electrochemical strategy can be employed to assay CK2 activity with a low detection limit of 0.07 U/mL. The linear range of the assay for CK2 was 0 U/mL to 0.5 U/mL. Furthermore, the interferences experiments of PKA and inhibition of CK2 have been also studied by using this strategy.

Highlights

► We develop a label-free electrochemical strategy for assay of CK2 and inhibition. ► The electrochemical assay is based on TiO2/MWNTs nanocomposites. ► Specific binding of the phosphate groups with TiO2nanoparticles. ► Fast electron transfer rate of MWNTs. ► Providing a general platform for monitoring the activity of other kinases.

A novel approach to determining the affinity of protein-carbohydrate interactions employing adherent cancer cells grown on a biosensor surface

25 February 2012, 21:52:54Go to full article
Publication year: 2012
Source: Biosensors and Bioelectronics, Available online 25 February 2012
Diluka Peiris, Anatoliy Markiv, G. Paul Curley, Miriam V. Dwek
The development of biological agents for the treatment of solid tumours is an area of considerable activity. We are pursuing carbohydrate-binding proteins (lectins) in a strategy aimed at targeting cancer-associated changes in glycosylation. To evaluate lectin-cancer cell interactions we developed a novel cell biosensor in which binding events take place at the cell surface, more closely mimicking anin vivosystem. Metastatic, SW620, and non-metastatic, SW480, colorectal cancer cells were grown on the surface of a tissue-culture compatible polystyrene coated biosensor chip and housed in a quartz crystal microbalance (QCM) apparatus, the kinetics of binding of a diverse range of lectins was evaluated. The lectinHelix pomatiaagglutinin (HPA) has been shown to bind aggressive metastatic cancer and was produced in recombinant form (His- and RFP-tagged). The affinity of HPA was in the nanomolar range to the metastatic SW620 cells but was only in the micromolar range to the non-metastatic SW480. Overall, the dissociation constant (KD) of the lectins tested in the new cell biosensor system was an order of magnitude lower (nanomolar range) than has generally been reported with systems such as QCM/SPR. This new cell-biosensor enables molecular interactions to be studied in a more relevant environment. An intrinsic problem with developing new biological therapies is the difficulty in determining the affinity with which proteins will interact with intact cell surfaces. This methodology will be of interest to researchers developing new biological approaches for targeting cell surfaces in a wide range of diseases, including cancer.

Highlights

► A novel system in which cells are grown on a biosensor chip is described. ► Affinity measurements are made directly at the cell surface. ► The sensor surface is regenerated and can be used for up to 30 experiments. ► A new method for testing novel biological reagents that target the cell surface.

A study of electrochemical biosensor for analysis of three-dimensional (3D) cell culture

25 February 2012, 21:52:54Go to full article
Publication year: 2012
Source: Biosensors and Bioelectronics, Available online 25 February 2012
Se Hoon Jeong, Dong Woo Lee, Sanghyo Kim, Jhingook Kim, Bosung Ku
Cell culture has a fundamental role not only in regenerative medicine but also in biotechnology, pharmacology, impacting both drug discovery and manufacturing. Although cell culture has been generally developed for only two-dimensional (2D) culture systems, three-dimensional (3D) culture is being spotlighted as the means to mimic in vivo cellular conditions. In this study, a method for cytotoxicity assay using an electrochemical biosensor applying 3D cell culture is presented. In order to strengthen the advantage of a 3D cell culture, the experimental condition of gelation between several types of sol-gels (alginate, collagen, matrigel) and cancer cells can be optimized to make a 3D cell structure on the electrode, which will show the reproducibility of electrical measurement for long-term monitoring. Moreover, cytotoxicity test results applying this method showed IC50value of A549 lung cancer cells to erlotinib. Thus, this study evaluates the feasibility of application of the electrochemical biosensor for 3D cell culture to cytotoxicity assay for investigation of 3D cell response to drug compounds.

Highlights

► Characterization of an electrochemical biosensor for analysis of 3D cell culture. ► Optimization for enhancement of electrical signal effectiveness in 3D cell culture. ► Electrochemical Measurement of cell viability according to cell seeding density. ► Drug dose response on the electrochemical biosensor applying 3D cell culture. ► We confirmed the feasibility of application of the electrochemical biosensor for analysis of 3D cell culture to cytotoxicity assay by investigating the drug efficacy of erlotinib with the biosensor.

SFT - HPR Series - High Pressure Chemical Reactors

Supercritical Fluid Technologies has a series of stirred reactors for high pressure chemistry. The HPR Series Reactors have been designed for researchers who are interested in performing pressurized chemical reactions in their laboratories. Whether it is high pressure chemical synthesis or process development, the HPR Series is an excellent unit for those applications.

The reactors range in size from 50 ml to 4 liters and may be operated up to 10,000 psi and 350°C. The reactors have a magnetically coupled impeller for optimal mixing. All high pressure components are ASME rated and protected by a rupture disc for safe operation. These laboratory bench top models are ideal for applications where repetitive use makes convenience a necessity, such as catalytic studies, polymerization, hydrogenation, oxidation, isomerization, and dehydrogenation. All sizes are supplied as ready-to-use instruments requiring only utility connections prior to operation. The reactors are compact instruments that fit easily into a fume hood. Their modular design makes it simple and cost-effective to alter the unit’s basic configuration to adapt to new or evolving application needs.

All functions for the HPR Series Reactor are controlled by choices of three integrated RxTrol™ processors. The RxTrol Sr. offer advanced features utilizing a microcontroller to perform all PID, ramp/soak, process trending, mixing and interlock functions.  The RxTrol Jr. consists of (2) temperature sensors (wall/interior mounting), and fuzzy logic PID temperature controls and mixing controls in a table top assembly.  The RxTrol B consists of (2) temperature sensors (wall/interior mounting) and an open loop mixer speed control via 0-100% power output knob. 

Additional options include vessel windows (<150 degrees Celsius operation only), additional ports, cooling coils, sample loops, stand alone pressure transducers, supercritical fluids pumps and reagent addition modules.

For more information, please call us at 302-738-3420 or visit us on-line at www.supercriticalfluids.com.